YQ:NASDAQ17 Education & Technology Group Inc. Analysis
Data as of 2026-05-28 - not real-time
$2.58
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The short‑term moving average sits above the intermediate average but remains below the long‑term average, indicating a neutral bias. Momentum indicators are modestly positive, with the MACD line above its signal and the RSI hovering in the mid‑fifties, while trading volume has been slipping and price action is confined between a clear support zone and a modest resistance ceiling.
Fundamental backdrop: The company reports operating losses and negative earnings, yet it holds a strong cash position and minimal debt, translating into valuation multiples that are well below typical market levels. However, the sector faces heightened regulatory scrutiny in China, volatility is exceptionally high, and the stock’s liquidity is limited, all of which temper the attractiveness of the current discount.
Fundamental backdrop: The company reports operating losses and negative earnings, yet it holds a strong cash position and minimal debt, translating into valuation multiples that are well below typical market levels. However, the sector faces heightened regulatory scrutiny in China, volatility is exceptionally high, and the stock’s liquidity is limited, all of which temper the attractiveness of the current discount.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near established support
- declining trading volume
- persistent earnings deficits
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- substantially low price‑to‑book and price‑to‑sales ratios
- robust cash reserves relative to modest debt
- potential easing of regulatory pressure
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- deep valuation discount offering upside potential
- strong balance sheet providing runway for strategic initiatives
- long‑term growth prospects in the Chinese ed‑tech market if policy environment stabilizes
Key Metrics & Analysis
Financial Health
Revenue Growth6.40%
Profit Margin-145.64%
P/E Ratio-0.9
ROE-45.40%
ROA-17.93%
Debt/Equity5.12
P/B Ratio0.7
Technical Analysis
TrendNeutral
RSI55.8
Support$2.00
Resistance$3.04
MA 20$2.47
MA 50$2.26
MA 200$3.41
MACDBullish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.52
Volatility105.23%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.